Updated on 11 September 2026
Expertise for HORIZON-MISS-2027-02-CANCER-01
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania
About
Lithuanian University of Health Sciences (LSMU) provides a strong environment for translational oncology research, integrating clinical expertise with biomedical and molecular research. Through its close links with Hospital of LSMU Kauno klinikos, researchers have access to diverse cancer patient populations and clinical data supporting precision oncology initiatives. LSMU is interested in projects combining functional genomics, biomarker discovery, molecular profiling, and personalized treatment approaches. The institution can contribute expertise in translating biological discoveries into clinically relevant applications and validating novel therapeutic strategies. Participation in international consortia would strengthen efforts to identify innovative targets for cancer treatment and accelerate their implementation in clinical practice.
Topic
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Expertise for HORIZON-MISS-2027-02-CANCER-01
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Rita Kupcinskaite
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Expertise for HORIZON-MISS-2027-02-CANCER-03
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Erika Korobeinikova
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Expertise in HORIZON-MISS-2027-02-CANCER-04
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Rita Kupcinskaite
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania